Update on polycystic ovary syndrome
Jin Ju Kim
Clin Exp Reprod Med. 2021;48(3):194-197.   Published online 2021 Aug 24     DOI: https://doi.org/10.5653/cerm.2020.04329
Citations to this article as recorded by Crossref logo
The ameliorating effects of apigenin and chrysin alone and in combination on polycystic ovary syndrome induced by dehydroepiandrosterone in rats
Buket Berk, Nevin İlhan, Solmaz Susam, Fatma Tedik, Nalan Kaya Tektemur
Marmara Medical Journal.2024; 37(2): 198.     CrossRef
Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatmentstill long time to reach clinical arena: a narrative review
Kulvinder Kochar Kaur, Gautam Nand Allahbadia, Mandeep Singh
MOJ Women s Health.2023; 12(2): 31.     CrossRef
Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
Qiaoli Zhang, Rongcai Ye, Yuan-Yuan Zhang, Chen-Chen Fan, Jun Wang, Shuyu Wang, Suwen Chen, Xiaowei Liu
Frontiers in Endocrinology.2022;[Epub]     CrossRef
Age-Adjusted Prevalence and Characteristics of Women with Polycystic Ovarian Syndrome in Korea: A Nationwide Population-Based Study (2010–2019)
Ju Hee Kim, Min Hyung Jung, Se Hwa Hong, Nalae Moon, Dae Ryong Kang
Yonsei Medical Journal.2022; 63(8): 794.     CrossRef
Effects of Exposure Duration and Exposure Levels of Ambient Air Pollutants on the Risk of Polycystic Ovarian Syndrome: A 2015–2019 Korean Population-Based Cohort Study
Ju-Hee Kim, Se-Hwa Hong, Na-Lae Moon, Dae-Ryong Kang
Toxics.2022; 10(9): 542.     CrossRef